Holder snapshot 6 signals
Share change
+9,505,365
SEC-reported price per share
$16.70
Number of holders
38
Value change
+$147,088,157
Number of buys
18
Number of sells
29
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
153,608,082

Security key

152309100

Report period

Q3 2021

Institutions

38

Top holders

10

Ownership snapshot

Top reported holders of CNTA - Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (the "Ordinary Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Medicxi Ventures Manageme...
Disclosed value leader
Medicxi Ventures Manageme...
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F Lead comparable stake: 12% Showing 1-6 of 15 holder rows.

Quick read

Medicxi Ventures Management (Jersey) Ltd leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Medicxi Ventures Management (Jersey) Ltd's linked filing trail.
Comparable ownership Top 5
Medicxi Ventures Management (Jers... 12%
JANUS HENDERSON GROUP PLC 3.7%
Vida Ventures Advisors, LLC 2.6%
PRICE T ROWE ASSOCIATES INC /MD/ 1.3%
Samsara BioCapital, LLC 1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Medicxi Ventures Management (Jersey) Ltd
13F
Company
13F
12%
$398,090,000
17,923,892 shares
30 Jun 2021
JANUS HENDERSON GROUP PLC
13F
Company
13F
3.7%
$120,122,000
5,680,933 shares
30 Jun 2021
Vida Ventures Advisors, LLC
13F
Company
13F
2.6%
$87,326,000
3,931,818 shares
30 Jun 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
1.3%
$43,858,000
2,011,073 shares
30 Jun 2021
Samsara BioCapital, LLC
13F
Company
13F
1%
$34,149,000
1,537,533 shares
30 Jun 2021
GENERAL ATLANTIC, L.P.
13F
Company
13F
0.98%
$33,315,000
1,500,000 shares
30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
38
Shares
52,983,439
Rows available
38
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
49
Q3 2021 holders
38
Holder diff
-11
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .